Back to User profile » Dr Dina S. El-Agamy
Paper published by Dr Dina S. El-Agamy:
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways
El-Agamy DS, El-Harbi KM, Khoshhal S, Ahmed N, Elkablawy MA, Shaaban AA, Abo-Haded HM
Cancer Management and Research 2019, 11:47-61
Published Date: 19 December 2018